Effect of Immunomodulating Adjuvant Dzherelo (Immunoxel) in HIV Infected Patients Receiving Standard Antiretroviral Therapy

por Nikolaeva, Lyudmila G, Maystat, Tatiana V, Volyanskii, Yuri L, Pylypchuk, Volodymyr S, Frolov, Valery M, Kutsyna, Galyna A
Publicado 2009

Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients

por Nikolaeva, Lyudmila G, Maystat, Tatyana V, Masyuk, Lilia A, Pylypchuk, Volodymyr S, Volyanskii, Yuri L, Kutsyna, Galyna A
Publicado 2009

Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC

por Tarakanovskaya, Marina G, Chinburen, Jigjidsuren, Purevsuren, Genden, Munkhzaya, Chogsom, Batchuluun, Purev, Bat-Ireedui, Purev, Dandii, Dorjiin, Oyungerel, Dandii, Kutsyna, Galyna A, Bain, Allen I, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado 2015

Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

por Tarakanovskaya, Marina G, Chinburen, Jigjidsuren, Batchuluun, Purev, Munkhzaya, Chogsom, Purevsuren, Genden, Dandii, Dorjiin, Hulan, Tsogkhuu, Oyungerel, Dandii, Kutsyna, Galyna A, Reid, Alan A, Borisova, Vika, Bain, Allen I, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado 2017